Trump continues to see hydroxychloroquine as promising against COVID-19 - White House

WASHINGTON (Reuters) - U.S. President Donald Trump continues to see a malaria drug, hydroxychloroquine, as a promising drug to be used to prevent infection with the coronavirus, the White House said on Thursday, though the U.S. Food and Drug Administration has said its efficacy and safety were unproven.

Reuters July 10, 2020 01:11:14 IST
Trump continues to see hydroxychloroquine as promising against COVID-19 - White House

COVID-19 - White House" src="https://images.firstpost.com/wp-content/uploads/reuters/07-2020/10/2020-07-09T184538Z_1_LYNXMPEG681N2_RTROPTP_2_HEALTH-CORONAVIRUS-HYDROXYCHLOROQUINE.jpg" alt="Trump continues to see hydroxychloroquine as promising against COVID19 White House" width="300" height="225" />

WASHINGTON (Reuters) - U.S. President Donald Trump continues to see a malaria drug, hydroxychloroquine, as a promising drug to be used to prevent infection with the coronavirus , the White House said on Thursday, though the U.S. Food and Drug Administration has said its efficacy and safety were unproven.

"The president has always said that he sees hydroxychloroquine as a very promising prophylactic but that every person should not take it unless they get a prescription from their doctor," White House spokeswoman Kayleigh McEnany said at a news conference.

(Reporting by Jeff Mason; Writing by Makini Brice; Editing by Chizu Nomiyama)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

Under-supplied palladium races to record, gold awaits Fed
Business

Under-supplied palladium races to record, gold awaits Fed

By Eileen Soreng (Reuters) - Palladium prices hit a record on Tuesday, spurred by persistent supply worries, while gold held a narrow range as investors awaited policy signals from the U.S. Federal Reserve's meeting this week. Palladium hit a record of $2,962.50 per ounce earlier and was up 0.8% at $2,948.69 per ounce by 1:02 p.m

General Electric reports smaller cash outflow, reaffirms 2021 outlook
Business

General Electric reports smaller cash outflow, reaffirms 2021 outlook

By Rajesh Kumar Singh and Ankit Ajmera (Reuters) -General Electric's cash outflow was smaller than estimated in the first quarter even as its lucrative jet-engine business struggled with the pandemic-led collapse of air travel, driving down company revenue. The company also reaffirmed its full-year free cash flow and earnings per share outlook

Oil rises as OPEC+ seen sticking to policy despite India COVID surge
Business

Oil rises as OPEC+ seen sticking to policy despite India COVID surge

By Devika Krishna Kumar NEW YORK (Reuters) - Oil prices edged higher on Tuesday as OPEC+ was expected to stick to existing plans to boost oil output slightly from May 1, suggesting it does not see a lasting impact on demand from India's coronavirus crisis. The group has also ditched plans to hold a full ministerial meeting on Wednesday, sources said. A technical meeting on Monday had voiced concern about surging COVID-19 cases but kept its oil demand forecast unchanged.